Bit Bio locks in $41.5m Series A

UK-based Bit Bio, a synthetic biology company, has closed $41.5 million in Series A funding.

UK-based Bit Bio, a synthetic biology company, has closed $41.5 million in Series A funding. The investors included Foresite Capital, Blueyard Capital and Arch Venture Partners.

Source: Press Release